April 2006
Worldwide Biotech;Apr2006, Vol. 18 Issue 4, p8
Trade Publication
Reports on the contract from the National Health Service in Great Britain received by the European subsidiary of Baxter International Inc. to produce a stockpile of candidate H5N1 influenza vaccine based on an avian strain. Terms of the contract; Remarks from Joy Amundson, corporate vice president and president of Baxter's BioScience business, regarding the contract; Development of a cell culture-based H5N1 candidate pandemic influenza vaccine.


Related Articles

  • The buck stops at the top. Scott, Graham // Nursing Standard;1/12/2011, Vol. 25 Issue 19, p1 

    The article presents an editorial which looks at health crisis scares in Great Britain, focusing on rumors of vaccination shortages. The efforts of Great Britain's National Health Service (NHS) to supply influenza immunizations are discussed. The Joint Committee on Vaccination and Immunisation...

  • Baxter Receives Marketing Authorization in European Union for VEPACEL Pre- Pandemic Influenza Vaccine.  // Biomedical Market Newsletter;3/7/2012, Vol. 21, p1 

    The article reports that the marketing authorization of pre-pandemic influenza vaccine VEPACEL of Baxter International Inc. has been granted by the European Commission (EC). It is mentioned that the vaccine has been made with the use of Vero cell technology in which natural influenza virus is...

  • Baxter fighting bird flu.  // R&D Magazine;Feb2007, Vol. 49 Issue 2, p26 

    The article reports on a Memorandum of Understanding signed by medical manufacturer Baxter International with the Indonesian government to help fight the bird flu there. Baxter has been working with the World Health Organization in Great Britain, U.S., Japan and Australia to access newly...

  • Potential role of flu vaccines, respiratory illness unknown.  // Infectious Disease News;Jul2013, Vol. 26 Issue 7, p17 

    The article discusses the results of a study led by Doctor Edward A. Belongia published in an online 2013 issue of the "Clinical Infectious Diseases Journal" which showed that influenza vaccines can lessen the risk of developing other respiratory viruses.

  • New Flu-Shot Schedule. L. H. // Good Housekeeping;Nov2008, Vol. 247 Issue 5, p97 

    The article offers information on the significance of flu-shots to children in the U.S. These are not just for small children, but it is advisable for everybody until 19 years of age. Research shows that 30% of children catch flue in a bad outbreak and they often infect those who can get...

  • RCGP wants flu vaccine offered to all GPs.  // Pulse;3/4/2009, Vol. 69 Issue 7, p2 

    The article reports on the suggestion of the Royal College of General Practitioners (RCGP) to general practitioners (GPs) and National Health Service (NHS) managers to offer annual flu vaccinations to their staff in Great Britain. RCGP believes that vaccination prevents the spread of infection...

  • Flu vaccine.  // New Statesman & Society;2/24/95, Vol. 8 Issue 341, p8 

    Reports that the National Health Service spent 28 million pounds on influenza vaccine in 1993-94.

  • In numbers - Fighting flu.  // GP: General Practitioner;7/22/2013, p04 

    The article reports that officials of Great Britain National Health Service (NHS) have relaunched the NHS Flu Fighter campaign to encourage NHS staff to be vaccinated.

  • Influenza. Cheung, Michele; Lieberman, Jay M. // Contemporary Pediatrics;Oct2002, Vol. 19 Issue 10, p96 

    Discusses the importance of vaccination in the treatment, management and prevention of influenza and influenza viruses in the U.S. Types of influenza; Information on the licensed vaccines for influenza in the country; Information on the side effects of inactivated influenza vaccine. INSET: The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics